Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Multimillion rand donation to boost UFS schools
2013-02-05

At the launch were Dr Cobus van Breda, Director of the Science-for-the- Future Unit at the UFS, Mr Makhetha Botsane from the Free State Department of Education Mrs. Elizna Prinsloo, Programme Manager of the Family Maths and Family Science project and Mr Graham McCulloch, Free State representative of the Ilima Trust.
Photo: Kelly Abrahams
05 February 2013

The University of the Free State’s UFS) Family Maths and Family Science project has received a R1 million sponsorship from Old Mutual for 2013. This is a three-year project whereby the university’s School of Open Learning aims to demystify mathematics and science in the early school years, as stated in their mission. The launching ceremony took place on 1 February 2013 at the UFS Campus.

The sponsorship was made available by Old Mutual, but will be managed by the project management group, Ilima Trust.

The UFS received R30 million altogether from Old Mutual for the use on various projects.

Except for the Family Maths and Family Science project, the Schools make over project and the Internet Broadcasting Programme will also benefit from this donation.

“Ilima has a hands-on relationship with different projects and is the public face for the FM & FS sponsorship,” said Mr Graham McCulloch, Ilima Trust representative for the Free State.

“Today is the first step on the long road to improving math and science in the country,” McCulloch said.

Dr Cobus van Breda, Director of the Science-for-the-Future Unit  says the Family Math and Family Science Project makes science and math accessible to children and their parents in the early years, with the aim of developing positive attitudes towards these often difficult school subject.

“This project aims to empower educators, parents and student educators by iving support and training in hands-on teaching methodologies.”

Learners, educators and parents from 18 schools in Thaba Nchu and Botshabelo will benefit from this project. Teachers will receive training at the UFS and then return to their community to train parents and to teach learners. Teachers will also receive activity material to use in classrooms.

“The selection of the 18 participating schools took place by identifying feeder schools of secondary schools from the UFS School Change Project, trying to create a whole-school development,” Van Breda said.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept